Skip the Trip? Five Arguments on the Use of Nonhallucinogenic Psychedelics in Psychiatry
Andrew Peterson, Dominic Sisti
Cambridge Quarterly of Healthcare Ethics October 1, 2022 DOI: 10.1017/s0963180122000081 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Citations | 11 |
| Key points | Argues that psychedelic-assisted therapy can produce significant changes in personal identity, which should be recognized as a key ethical issue in clinical practice. |
Abstract
Andrew Peterson* and Dominic Sisti Institute for Philosophy and Public Policy and Department of Philosophy, George Mason University, Fairfax, Virginia 22030, USA Penn Program on Precision Medicine for the Brain, University of Pennsylvania Memory Center, Philadelphia, Pennsylvania 19104, USA Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA *Corresponding author. Email: apeter31@gmu.edu